Marinomed Biotech AG (MARI) Stock Price & News

All values in EUR	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	6.50M	918.87K	270.60K	270.60K
Cost of goods sold	-	1.29M	64.77K	64.77K
Cost of revenue	-	1.29M	64.77K	64.77K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	2.19M	905.56K	905.56K
Operating expense	-15.70M	19.78M	1.36M	1.36M
Total operating expenses	-15.70M	21.07M	1.43M	1.43M
Operating income	22.20M	-20.15M	-1.16M	-1.16M
Other non operating income	-	10.02K	4.53K	4.53K
EBT including unusual items	22.20M	-1.50M	-1.29M	-1.29M
EBT excluding unusual items	22.20M	-20.41M	-1.29M	-1.29M
Income tax expense	100.00K	-117.13K	61.62K	61.62K
Effective tax rate	0.45%	7.83%	-4.78%	-4.78%
Other operating expenses	-15.70M	17.42M	382.00K	382.00K
Net income	22.10M	-1.38M	-1.35M	-1.35M
Net profit margin	340.00%	-150.15%	-499.28%	-499.28%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-270.32K	-136.49K	-136.49K
Net interest expenses	-	-270.32K	-136.49K	-136.49K
Depreciation and amortization charges	-	160.49K	75.70K	75.70K
EBITDA	22.30M	-20.07M	-1.08M	-1.08M
Gain or loss from assets sale	-	-	-	-

Finance